ANFOSSI, Giovanni
 Distribuzione geografica
Continente #
EU - Europa 2.252
NA - Nord America 2.164
AS - Asia 952
AF - Africa 11
OC - Oceania 6
Totale 5.385
Nazione #
US - Stati Uniti d'America 2.111
CN - Cina 666
UA - Ucraina 411
IE - Irlanda 355
DE - Germania 312
FI - Finlandia 245
IT - Italia 238
KR - Corea 230
SE - Svezia 179
FR - Francia 178
GB - Regno Unito 136
PL - Polonia 107
AT - Austria 63
CA - Canada 50
VN - Vietnam 32
BE - Belgio 10
GR - Grecia 9
IR - Iran 9
IN - India 8
SN - Senegal 8
AU - Australia 5
NL - Olanda 5
MX - Messico 3
SG - Singapore 3
ES - Italia 2
TW - Taiwan 2
JP - Giappone 1
MD - Moldavia 1
MU - Mauritius 1
NZ - Nuova Zelanda 1
SI - Slovenia 1
TN - Tunisia 1
UZ - Uzbekistan 1
ZA - Sudafrica 1
Totale 5.385
Città #
Beijing 568
Dublin 354
Jacksonville 259
Chandler 255
Houston 162
Princeton 138
Medford 121
Warsaw 105
Ann Arbor 98
Villeurbanne 96
Dearborn 85
Boston 75
Milan 69
Vienna 63
Fremont 60
Torino 53
Wilmington 51
Nyköping 47
Verona 47
Lachine 34
Ashburn 33
Philadelphia 27
Dong Ket 23
Fairfield 21
Boardman 20
Norwalk 20
Falls Church 18
Toronto 16
Hefei 14
New York 14
Kunming 11
Brussels 10
Athens 9
Detroit 9
Savona 9
Guangzhou 8
Nanjing 7
Pune 7
Woodbridge 7
Ardabil 6
Jinan 6
Monmouth Junction 6
Pasadena 6
Anguillara 5
Hebei 5
Nanchang 5
Phoenixville 5
Rome 5
Shenyang 5
Zhengzhou 5
San Mateo 4
Hangzhou 3
Leawood 3
Shanghai 3
Sydney 3
Wuhan 3
Bellinzago Novarese 2
Changsha 2
Chengdu 2
Düsseldorf 2
Genova 2
Giulianova 2
Grammichele 2
Helsinki 2
Huzhou 2
Kharkiv 2
Lucera 2
Mountain View 2
Napoli 2
Ortona 2
Redmond 2
Redwood City 2
Shaoxing 2
Tabriz 2
Tappahannock 2
Turin 2
Africo 1
Anzio 1
Auburn Hills 1
Auckland 1
Brooklyn 1
Cambridge 1
Canosa di Puglia 1
Chiba 1
Chisinau 1
Chongqing 1
Cornigliano 1
Des Moines 1
Fuzhou 1
Groningen 1
Haikou 1
Hanoi 1
Jinhua 1
Kilcock 1
Lake Forest 1
Langfang 1
Ljubljana 1
Madison 1
Maida Hill 1
Melbourne 1
Totale 3.165
Nome #
High glucose reduces the anti-aggregating effect of aspirin by impairing the aspirin-induced activation of the nitric oxide/cGMP/PKG pathway. 118
Le dislipidemie Aspetti biochimici e clinici 105
Evaluation of a simple policy for pre- and post-prandial blood glucose self-monitoring in people with type 2 diabetes not on insulin 102
The Cardiovascular Effects of Metformin: Further Reasons to Consider an Old Drug as a Cornerstone in the Therapy of Type 2 Diabetes Mellitus 99
Expression of the c-myc protooncogene product in cells infected with the hepatitis delta virus 90
Platelet resistance to the antiaggregatory cyclic nucleotides in central obesity involves reduced phosphorylation of vasodilator-stimulated phosphoprotein 82
Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance 75
Relevance of the vascular effects of insulin in the rationale of its therapeutical use 74
In Central Obesity, Weight Loss Restores Platelet Sensitivity to Nitric Oxide and Prostacyclin 73
Contribution of insulin resistance to vascular dysfunction 72
High Glucose Inhibits the Aspirin-Induced Activation of the Nitric Oxide/cGMP/cGMP-Dependent Protein Kinase Pathway and Does Not Affect the Aspirin-Induced Inhibition of Thromboxane Synthesis in Human Platelets. 70
Effects of high glucose on vascular endothelial growth factor synthesis and secretion in aortic vascular smooth muscle cells from obese and lean zucker rats. 68
Insulin activates hypoxia-inducible factor-1alpha in human and rat vascular smooth muscle cells via phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways: impairment in insulin resistance owing to defects in insulin signalling 68
Immunomorphological aspects of the kidney in liver cirrhosis and obstructive jaundice 64
Clinically autonomous hepatic tuberculosis] 63
Effect of dopamine on adenosine 3',5'-cyclic monophosphate levels in human platelets. 63
Urinary enzyme release following aminoglycoside administration in single low dose. 62
Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect. 62
Resistance to aspirin and thienopyridines in diabetes mellitus and metabolic syndrome 61
A double blind randomized placebo-controlled study demonstrates the protective efficacy of rosaprostol on aspirin-induced gastrointestinal bleeding in man. 60
C-reactive protein increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells 60
White blood cell count is positively correlated with albumin excretion rate in subjects with type 2 diabetes 59
Comparison between the effects of the rapid recombinant insulin analog aspart and those of human regular insulin on platelet cyclic nucleotides and aggregation. 58
Insulin influences the nitric oxide cyclic nucleotide pathway in cultured human smooth muscle cells from corpus cavernosum by rapidly activating a constitutive nitric oxide synthase. 57
Cryptococcosis in a female patient with angioimmunoblastic lymphadenopathy and dysproteinemia 56
Nitric oxide activates PI3-K and MAPK signalling pathways in human and rat vascular smooth muscle cells: influence of insulin resistance and oxidative stress. 56
Role of NMDA receptor in homocysteine-induced activation of Mitogen-Activated Protein Kinase and Phosphatidyl Inositol 3-Kinase pathways in cultured human vascular smooth muscle cells 55
Alpha-adrenergic blockade with phentolamine increases the response of the renin-angiotensin-aldosterone system to insulin-induced hypoglycaemia in man. 54
Type B viral hepatitis. Recent findings 52
Effects of diltiazem on thromboxane B2 production from platelet-rich plasma and whole blood 52
Pathogenetic aspects of cholemic nephropathy 52
A Platelet Defect Characterised by Absent Adrenaline-induced Aggregation and Lack of Secondary Aggregation in Response to ADP and Platelet-activating Factor. 52
Bile salts and spontaneous release of PGI2, TxA2 and fVIII from cultured human endothelial cells 52
Sodium taurocholate affects prostacyclin constitutive production by cultured human vascular endothelial cells. 52
Changes of renal lactate dehydrogenase isoenzymes (LDH) in the course of acute experimental tubular necrosis 52
Cholemic tubulonephrosis 52
c-myc expression in cells infected with hepatitis delta virus. 51
Immunologic sensitization of circulating basophils to exogenous insulin in diabetic patients. 51
Arginine vasopressin release from human platelets after irreversible aggregation. 51
Sodium azide, a bacteriostatic preservative contained in commercially available laboratory reagents, influences the responses of human platelets via the cGMP/PKG/VASP pathway. 50
Use of urinary enzymes to evaluate renal damage. Physiopathological considerations and clinical applications 49
Proteina C-reattiva: dosare o non dosare nel paziente diabetico 49
N-acetyl-L-cysteine exerts direct anti-aggregating effect on human platelets. 49
Adipocytokines in atherothrombosis: focus on platelets and vascular smooth muscle cells. 49
Effects of forskolin and organic nitrate on aggregation and intracellular cyclic nucleotide content in human platelets. 48
Catecholamines, via beta-adrenoceptors, increase intracellular concentrations of 3',5'-cyclic guanosine monophosphate (cGMP) through nitric oxide in human platelets. 48
Calcium-channel blocking agents verapamil and diltiazem are inhibitors of vasopressin-induced human platelet activation. 48
Postprandial blood glucose predicts cardiovascular events and all-cause mortality in type 2 diabetes in a 14-year follow-up: lessons from the San Luigi Gonzaga Diabetes Study. 48
Oleic acid increases synthesis and secretion of VEGF in rat vascular smooth muscle cells: role of oxidative stress and impairment in obesity. 48
Urinary enzyme excretion and renal lactate dehydrogenase isoenzyme pattern in acute HgCl2 nephropathy of rat. 48
Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells 47
An oligomer complementary to c-myb-encoded mRNA inhibits proliferation of human myeloid leukemia cell lines. 47
A comparison of the predictive power for overall blood glucose control of a 'good' fasting level in type 2 diabetic patients on diet alone or with oral agents 47
Blood glucose pre-prandial baseline decreases from morning to evening in type 2 diabetes: role of fasting blood glucose and influence on post-prandial excursions. 45
Comparison between the effects of the rapid recombinant insulin analog LYSPRO (Lys B28, Pro B29) and those of human regular insulin on platelet cyclic nucleotides and aggregation 45
Urinary enzyme excretion in acute and subacute experimental lithium administration 44
Platelet resistance to the antiaggregating effect of N-acetyl-L-cysteine in obese, insulin-resistant subjects. 43
Studies on inhibition of human platelet function by sodium nitroprusside. Kinetic evaluation of the effect on aggregation and cyclic nucleotide content. 42
Na+/H+ antiporter activity in peripheral blood lymphocytes of obese and type 2 diabetic patients is increased only in the presence of arterial hypertension. 42
Influence of urapidil on in vitro platelet response to adrenaline and other aggregating agents. 41
Influence of insulin and of insulin resistance on platelet and vascular smooth muscle cell function. 41
Insulin increases cyclic nucleotide content in human vascular smooth muscle cells: a mechanism potentially involved in insulin-induced modulation of vascular tone. 41
Studies on in vitro effect of picotamide on human platelet aggregation in platelet-rich plasma and whole blood. 41
Renal lactate dehydrogenase (LDH) isoenzyme pattern in short-term experimental obstructive nephropathy. 40
Effects of anti-adrenergic drugs on thrombin-induced platelet aggregation and thromboxane B2 production 40
Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga Diabetes Study 40
Human vascular smooth muscle cells express a constitutive nitric oxide synthase that insulin rapidly activates, thus increasing guanosine 3':5'-cyclic monophosphate and adenosine 3':5'-cyclic monophosphate concentrations. 40
Prescription of statins to dyslipidemic patients affected by liver diseases: a subtle balance between risks and benefits 40
Na+/H+ antiporter properties in peripheral blood lymphocytes from normotensive obese and type 2 diabetic patients do not differ significantly from controls. 39
G1/S transition in normal human T-lymphocytes requires the nuclear protein encoded by c-myb. 39
Intrahepatic exIntrahepatic expression of c-fos, c-myb and c-myc oncogenes: correlation with virus-induced chronic liver disease and response to interferon. 39
High glucose rapidly activates the nitric oxide/cyclic nucleotide pathway in human platelets via an osmotic mechanism 39
Phenothiazine compounds enhance phentolamine effects on platelet aggregation and thromboxane B2 production. 39
Consensus on: Screening and therapy of coronary heart disease in diabetic patients. 39
Insulin increases guanosine-3',5'-cyclic monophosphate in human platelets. A mechanism involved in the insulin anti-aggregating effect. 38
Studies on inhibition of human platelet response by diltiazem. 38
The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents 38
Role of catecholamines in platelet function: pathophysiological and clinical significance. 38
Desensitization of the platelet aggregation response to adrenaline during insulin-induced hypoglycaemia in man. 38
Insulin influences the renin-angiotensin-aldosterone system in humans. 38
Insulin stimulates the polymorphonuclear leukocyte chemokinesis. 37
Occurrence of low blood glucose concentrations during the afternoon in type 2 (non-insulin-dependent) diabetic patients on oral hypoglycaemic agents: importance of blood glucose monitoring. 37
Homocysteine rapidly increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. Role of phosphatidyl inositol 3-kinase and mitogen activated protein kinase pathways 37
Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3', 5'-cyclic monophosphate and adenosine-3', 5'-cyclic monophosphate 37
Transient massive hyperlipidaemia in a type 2 diabetic subject 37
Recovery of renal lactate dehydrogenase (LDH) isoenzyme pattern after obstruction relief in experimental hydronephrosis. 37
Influence of age on polymorphonuclear leukocytes in vitro: phagocytic activity in healthy human subjects 36
Insulin, insulin resistance and platelet function: similarities with insulin effects on cultured vascular smooth muscle cells 36
Phenothiazines inhibit collagen-induced thromboxane B2 synthesis and increase forskolin anti-aggregating effects in human platelets. 36
Platelet dysfunction in central obesity 36
Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress 36
Insulin exerts opposite effects on platelet function at physiological and supraphysiological concentrations. 35
Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost 35
Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM. 35
Insulin directly reduces platelet sensitivity to aggregating agents. Studies in vitro and in vivo. 35
Insulin, at physiological concentrations, enhances the polymorphonuclear leukocyte chemotactic properties. 35
Normal human T limphocytes G1/S transition requires the nuclear protein encoded by c-MYB protooncogene 34
Effect of labetalol on human platelet function. 34
Piastrine e complicanze del diabete 34
Insulin influences immunoreactive endothelin release by human vascular smooth muscle cells. 32
Totale 5.028
Categoria #
all - tutte 17.202
article - articoli 0
book - libri 0
conference - conferenze 263
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 17.465


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019138 0 0 0 0 0 0 0 0 0 24 88 26
2019/2020859 12 21 97 44 97 182 126 25 111 52 72 20
2020/2021582 72 19 92 16 27 11 69 7 125 80 19 45
2021/2022657 26 19 10 12 18 7 23 32 20 53 167 270
2022/2023982 144 37 22 42 122 327 121 46 80 15 23 3
2023/2024218 41 73 16 22 20 33 0 5 2 6 0 0
Totale 5.680